{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T04:38:42Z","timestamp":1779251922598,"version":"3.51.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2014,4,23]],"date-time":"2014-04-23T00:00:00Z","timestamp":1398211200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Virol"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1007\/s00705-014-2054-y","type":"journal-article","created":{"date-parts":[[2014,4,22]],"date-time":"2014-04-22T11:24:55Z","timestamp":1398165895000},"page":"2339-2347","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["In vitro and in vivo protection against enterovirus 71 by an antisense phosphorothioate oligonucleotide"],"prefix":"10.1007","volume":"159","author":[{"given":"Juan","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhe","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingming","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,4,23]]},"reference":[{"key":"2054_CR1","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1093\/infdis\/129.3.304","volume":"129","author":"NJ Schmidt","year":"1974","unstructured":"Schmidt NJ, Lennette EH, Ho HH (1974) An apparently new enterovirus isolated from patients with disease of the central nervous system. J Infect Dis 129:304\u2013309","journal-title":"J Infect Dis"},{"key":"2054_CR2","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0168-1702(95)00087-9","volume":"39","author":"BA Brown","year":"1995","unstructured":"Brown BA, Pallansch MA (1995) Complete nucleotide sequence of enterovirus 71 is distinct from poliovirus. Virus Res 39:195\u2013205","journal-title":"Virus Res"},{"key":"2054_CR3","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1006\/viro.1995.1450","volume":"212","author":"T Pulli","year":"1995","unstructured":"Pulli T, Koskimies P, Hyypia T (1995) Molecular comparison of coxsackie A virus serotypes. Virology 212:30\u201338","journal-title":"Virology"},{"key":"2054_CR4","doi-asserted-by":"crossref","first-page":"467","DOI":"10.2217\/fmb.12.22","volume":"7","author":"HI Huang","year":"2012","unstructured":"Huang HI, Weng KF, Shih SR (2012) Viral and host factors that contribute to pathogenicity of enterovirus 71. Future Microbiol 7:467\u2013479","journal-title":"Future Microbiol"},{"key":"2054_CR5","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jcv.2010.07.009","volume":"49","author":"LX Mao","year":"2010","unstructured":"Mao LX, Wu B, Bao WX, Han FA, Xu L et al (2010) Epidemiology of hand, foot, and mouth disease and genotype characterization of Enterovirus 71 in Jiangsu, China. J Clin Virol 49:100\u2013104","journal-title":"J Clin Virol"},{"key":"2054_CR6","doi-asserted-by":"crossref","first-page":"e1076","DOI":"10.1016\/j.ijid.2010.07.006","volume":"14","author":"Y Wu","year":"2010","unstructured":"Wu Y, Yeo A, Phoon MC, Tan EL, Poh CL et al (2010) The largest outbreak of hand; foot and mouth disease in Singapore in 2008: the role of enterovirus 71 and coxsackievirus A strains. Int J Infect Dis 14:e1076\u2013e1081","journal-title":"Int J Infect Dis"},{"key":"2054_CR7","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1007\/s00705-011-0929-8","volume":"156","author":"W De","year":"2011","unstructured":"De W, Changwen K, Wei L, Monagin C, Jin Y et al (2011) A large outbreak of hand, foot, and mouth disease caused by EV71 and CAV16 in Guangdong, China, 2009. Arch Virol 156:945\u2013953","journal-title":"Arch Virol"},{"key":"2054_CR8","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1016\/S0140-6736(99)04434-7","volume":"354","author":"LY Chang","year":"1999","unstructured":"Chang LY, Lin TY, Hsu KH, Huang YC, Lin KL et al (1999) Clinical features and risk factors of pulmonary oedema after enterovirus-71-related hand, foot, and mouth disease. Lancet 354:1682\u20131686","journal-title":"Lancet"},{"key":"2054_CR9","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1056\/NEJM199909233411301","volume":"341","author":"M Ho","year":"1999","unstructured":"Ho M, Chen ER, Hsu KH, Twu SJ, Chen KT et al (1999) An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic Working Group. N Engl J Med 341:929\u2013935","journal-title":"N Engl J Med"},{"key":"2054_CR10","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1056\/NEJM199909233411302","volume":"341","author":"CC Huang","year":"1999","unstructured":"Huang CC, Liu CC, Chang YC, Chen CY, Wang ST et al (1999) Neurologic complications in children with enterovirus 71 infection. N Engl J Med 341:936\u2013942","journal-title":"N Engl J Med"},{"key":"2054_CR11","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3109\/1040841X.2011.580723","volume":"37","author":"L Yi","year":"2011","unstructured":"Yi L, Lu J, Kung HF, He ML (2011) The virology and developments toward control of human enterovirus 71. Crit Rev Microbiol 37:313\u2013327","journal-title":"Crit Rev Microbiol"},{"key":"2054_CR12","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1086\/318454","volume":"32","author":"P McMinn","year":"2001","unstructured":"McMinn P, Stratov I, Nagarajan L, Davis S (2001) Neurological manifestations of enterovirus 71 infection in children during an outbreak of hand, foot, and mouth disease in Western Australia. Clin Infect Dis 32:236\u2013242","journal-title":"Clin Infect Dis"},{"key":"2054_CR13","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0022-3476(98)70155-6","volume":"133","author":"LC Lum","year":"1998","unstructured":"Lum LC, Wong KT, Lam SK, Chua KB, Goh AY et al (1998) Fatal enterovirus 71 encephalomyelitis. J Pediatr 133:795\u2013798","journal-title":"J Pediatr"},{"key":"2054_CR14","doi-asserted-by":"crossref","first-page":"4189","DOI":"10.1128\/JVI.69.7.4189-4197.1995","volume":"69","author":"BA Heinz","year":"1995","unstructured":"Heinz BA, Vance LM (1995) The antiviral compound enviroxime targets the 3A coding region of rhinovirus and poliovirus. J Virol 69:4189\u20134197","journal-title":"J Virol"},{"key":"2054_CR15","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1128\/AAC.43.9.2109","volume":"43","author":"DC Pevear","year":"1999","unstructured":"Pevear DC, Tull TM, Seipel ME, Groarke JM (1999) Activity of pleconaril against enteroviruses. Antimicrob Agents Chemother 43:2109\u20132115","journal-title":"Antimicrob Agents Chemother"},{"key":"2054_CR16","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.drudis.2010.10.008","volume":"15","author":"KX Wu","year":"2010","unstructured":"Wu KX, Ng MM, Chu JJ (2010) Developments towards antiviral therapies against enterovirus 71. Drug Discov Today 15:1041\u20131051","journal-title":"Drug Discov Today"},{"key":"2054_CR17","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1038\/nbt915","volume":"21","author":"LJ Scherer","year":"2003","unstructured":"Scherer LJ, Rossi JJ (2003) Approaches for the sequence-specific knockdown of mRNA. Nat Biotechnol 21:1457\u20131465","journal-title":"Nat Biotechnol"},{"key":"2054_CR18","doi-asserted-by":"crossref","first-page":"347","DOI":"10.4161\/cbt.1.4.4","volume":"1","author":"N Dias","year":"2002","unstructured":"Dias N, Stein CA (2002) Antisense oligonucleotides: basic concepts and mechanisms. Mol Cancer Ther 1:347\u2013355","journal-title":"Mol Cancer Ther"},{"key":"2054_CR19","unstructured":"Editorial PIP (1998) Advances in CMV management: fomivirsen (Vitravene) approved. Proj Inf Perspect: 7"},{"key":"2054_CR20","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.drudis.2008.03.014","volume":"13","author":"ER Rayburn","year":"2008","unstructured":"Rayburn ER, Zhang R (2008) Antisense, RNAi, and gene silencing strategies for therapy: mission possible or impossible? Drug Discov Today 13:513\u2013521","journal-title":"Drug Discov Today"},{"key":"2054_CR21","doi-asserted-by":"crossref","first-page":"4599","DOI":"10.1128\/JVI.79.8.4599-4609.2005","volume":"79","author":"TS Deas","year":"2005","unstructured":"Deas TS, Binduga-Gajewska I, Tilgner M, Ren P, Stein DA et al (2005) Inhibition of flavivirus infections by antisense oligomers specifically suppressing viral translation and RNA replication. J Virol 79:4599\u20134609","journal-title":"J Virol"},{"key":"2054_CR22","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1021\/bc025559y","volume":"13","author":"KD Jensen","year":"2002","unstructured":"Jensen KD, Kopeckova P, Kopecek J (2002) Antisense oligonucleotides delivered to the lysosome escape and actively inhibit the hepatitis B virus. Bioconjug Chem 13:975\u2013984","journal-title":"Bioconjug Chem"},{"key":"2054_CR23","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1574-695X.2007.00266.x","volume":"51","author":"Z Cong","year":"2007","unstructured":"Cong Z, Wan M, Wu X, Wang L, Hu X et al (2007) A CpG oligodeoxynucleotide inducing anti-coxsackie B3 virus activity in human peripheral blood mononuclear cells. FEMS Immunol Med Microbiol 51:26\u201334","journal-title":"FEMS Immunol Med Microbiol"},{"key":"2054_CR24","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1177\/135965350801300112","volume":"13","author":"M Duan","year":"2008","unstructured":"Duan M, Zhou Z, Lin RX, Yang J, Xia XZ et al (2008) In vitro and in vivo protection against the highly pathogenic H5N1 influenza virus by an antisense phosphorothioate oligonucleotide. Antivir Ther 13:109\u2013114","journal-title":"Antivir Ther"},{"key":"2054_CR25","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1006\/bbrc.2000.3924","volume":"279","author":"T Mizuta","year":"2000","unstructured":"Mizuta T, Fujiwara M, Abe T, Miyano-Kurosaki N, Yokota T et al (2000) Inhibitory effects of an antisense oligonucleotide in an experimentally infected mouse model of influenza A virus. Biochem Biophys Res Commun 279:158\u2013161","journal-title":"Biochem Biophys Res Commun"},{"key":"2054_CR26","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1177\/095632020301400201","volume":"14","author":"KL McKnight","year":"2003","unstructured":"McKnight KL, Heinz BA (2003) RNA as a target for developing antivirals. Antivir Chem Chemother 14:61\u201373","journal-title":"Antivir Chem Chemother"},{"key":"2054_CR27","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/nbt0507-497","volume":"25","author":"C Potera","year":"2007","unstructured":"Potera C (2007) Antisense\u2013down, but not out. Nat Biotechnol 25:497\u2013499","journal-title":"Nat Biotechnol"},{"key":"2054_CR28","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/1471-2105-7-122","volume":"7","author":"X Bo","year":"2006","unstructured":"Bo X, Lou S, Sun D, Shu W, Yang J et al (2006) Selection of antisense oligonucleotides based on multiple predicted target mRNA structures. BMC Bioinform 7:122","journal-title":"BMC Bioinform"},{"key":"2054_CR29","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nm.1992","volume":"15","author":"S Yamayoshi","year":"2009","unstructured":"Yamayoshi S, Yamashita Y, Li J, Hanagata N, Minowa T et al (2009) Scavenger receptor B2 is a cellular receptor for enterovirus 71. Nat Med 15:798\u2013801","journal-title":"Nat Med"},{"key":"2054_CR30","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1073\/pnas.75.1.285","volume":"75","author":"ML Stephenson","year":"1978","unstructured":"Stephenson ML, Zamecnik PC (1978) Inhibition of Rous sarcoma viral RNA translation by a specific oligodeoxyribonucleotide. Proc Natl Acad Sci USA 75:285\u2013288","journal-title":"Proc Natl Acad Sci USA"},{"key":"2054_CR31","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nrd3963","volume":"12","author":"MT Tse","year":"2013","unstructured":"Tse MT (2013) Regulatory watch: antisense approval provides boost to the field. Nat Rev Drug Discov 12:179","journal-title":"Nat Rev Drug Discov"},{"key":"2054_CR32","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1056\/NEJMoa042760","volume":"351","author":"ES Gragoudas","year":"2004","unstructured":"Gragoudas ES, Adamis AP, Cunningham ET Jr, Feinsod M, Guyer DR (2004) Pegaptanib for neovascular age-related macular degeneration. N Engl J Med 351:2805\u20132816","journal-title":"N Engl J Med"},{"key":"2054_CR33","doi-asserted-by":"crossref","first-page":"4631","DOI":"10.1128\/AAC.00650-11","volume":"55","author":"BW Neuman","year":"2011","unstructured":"Neuman BW, Bederka LH, Stein DA, Ting JP, Moulton HM et al (2011) Development of peptide-conjugated morpholino oligomers as pan-arenavirus inhibitors. Antimicrob Agents Chemother 55:4631\u20134638","journal-title":"Antimicrob Agents Chemother"},{"key":"2054_CR34","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.2174\/138161208786071290","volume":"14","author":"DA Stein","year":"2008","unstructured":"Stein DA (2008) Inhibition of RNA virus infections with peptide-conjugated morpholino oligomers. Curr Pharm Des 14:2619\u20132634","journal-title":"Curr Pharm Des"},{"key":"2054_CR35","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1038\/sj.mt.6300287","volume":"15","author":"EL Tan","year":"2007","unstructured":"Tan EL, Tan TM, Tak Kwong Chow V, Poh CL (2007) Inhibition of enterovirus 71 in virus-infected mice by RNA interference. Mol Ther 15:1931\u20131938","journal-title":"Mol Ther"},{"key":"2054_CR36","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.virol.2005.06.047","volume":"341","author":"AC Sim","year":"2005","unstructured":"Sim AC, Luhur A, Tan TM, Chow VT, Poh CL (2005) RNA interference against enterovirus 71 infection. Virology 341:72\u201379","journal-title":"Virology"},{"key":"2054_CR37","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.antiviral.2007.01.004","volume":"74","author":"EL Tan","year":"2007","unstructured":"Tan EL, Tan TM, Chow VT, Poh CL (2007) Enhanced potency and efficacy of 29-mer shRNAs in inhibition of Enterovirus 71. Antiviral Res 74:9\u201315","journal-title":"Antiviral Res"},{"key":"2054_CR38","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.bbrc.2004.10.062","volume":"325","author":"WW Lu","year":"2004","unstructured":"Lu WW, Hsu YY, Yang JY, Kung SH (2004) Selective inhibition of enterovirus 71 replication by short hairpin RNAs. Biochem Biophys Res Commun 325:494\u2013499","journal-title":"Biochem Biophys Res Commun"},{"key":"2054_CR39","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nrd3474","volume":"10","author":"D Jones","year":"2011","unstructured":"Jones D (2011) The long march of antisense. Nat Rev Drug Discov 10:401\u2013402","journal-title":"Nat Rev Drug Discov"},{"key":"2054_CR40","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/nature05901","volume":"448","author":"P Kumar","year":"2007","unstructured":"Kumar P, Wu H, McBride JL, Jung KE, Kim MH et al (2007) Transvascular delivery of small interfering RNA to the central nervous system. Nature 448:39\u201343","journal-title":"Nature"}],"container-title":["Archives of Virology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-014-2054-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00705-014-2054-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-014-2054-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T09:22:45Z","timestamp":1689153765000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00705-014-2054-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,23]]},"references-count":40,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["2054"],"URL":"https:\/\/doi.org\/10.1007\/s00705-014-2054-y","relation":{},"ISSN":["0304-8608","1432-8798"],"issn-type":[{"value":"0304-8608","type":"print"},{"value":"1432-8798","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,23]]}}}